Lista de obras -

2426 Fostering cross-disciplinary research: Lessons learned from STTEP-UP

2502 The need for an evidence-based CTS specific IDP for early career training and for a long-term and sustainable career in clinical translational sciences

2515 Cure Quest: Teaching the complexities of drug discovery and development through an adventure game

2517 Learning to LEAD: Leadership emerging in academic departments

2518 InCHOIR learning lab: A TL1 and workforce development initiative at Mount Sinai

artículo científico publicado en 2018

2527 Mount Sinai health hackathon: Harnessing the power of collaboration to advance experiential team science education

2547: Sinai MedMaker Challenge: A model of experiential team science education

artículo científico publicado en 2017

3144 Exploring communication and collaboration at the Mount Sinai Health Hackathon: a social network analysis

3297 What do early career researchers need? Exploring early career researchers’ learning needs to develop an Emerging Investigator website

3366 Communication in Science: a summer workshop program at Mount Sinai

artículo científico publicado en 2019

A path forward: Global health, telemedicine, and hematology

artículo científico publicado en 2016

Accelerators: Sparking Innovation and Transdisciplinary Team Science in Disparities Research

scientific article published on 23 February 2017

An analysis of current neutropenia therapies, including pegfilgrastim

artículo científico publicado en 2006

Anemia and the elderly: clinical considerations

artículo científico publicado en 2005

Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells

artículo científico publicado en 2018

Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks

artículo científico publicado en 2007

Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study.

artículo científico publicado en 2015

Benefits of epoetin alfa in anemic breast cancer patients receiving chemotherapy

artículo científico publicado en 2002

Cancer incidence in World Trade Center rescue and recovery workers, 2001-2008

artículo científico publicado en 2013

Clinical benefits of epoetin alfa therapy in patients with lung cancer

artículo científico publicado en 2002

Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes

artículo científico publicado en 2014

Creating effective career development programs

article

Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1 ⬇️

artículo científico publicado el 18 de octubre de 2012

Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia

artículo científico publicado en 2015

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

artículo científico publicado en 2006

Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity

artículo científico publicado en 2005

Granulocyte colony stimulating factor for mucositis during post-operative radiotherapy

artículo científico publicado en 2006

Intraoperative acute tumor lysis syndrome during laparoscopic splenectomy preceded by splenic artery embolization

artículo científico publicado en 2007

Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia ⬇️

artículo científico publicado el 24 de octubre de 2011

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

artículo científico publicado en 2010

Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma

artículo científico publicado en 2010

Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes

artículo científico publicado en 2008

Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

artículo científico publicado en 2016

Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors

artículo científico publicado en 2009

Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IP

artículo científico publicado en 2014

Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.

artículo científico publicado en 2014

Prospective cohort study of the circadian rhythm pattern in allogeneic sibling donors undergoing standard granulocyte colony-stimulating factor mobilization

artículo científico publicado en 2013

Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL.

artículo científico publicado en 2018

Signaling pathways in lymphoma: pathogenesis and therapeutic targets

artículo científico

Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells

artículo científico publicado en 2015

Statistical explanations for a community-based study of once-weekly epoetin alfa therapy in patients receiving chemotherapy

scientific article published on 01 June 2002

Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators.

artículo científico publicado en 2015

Transition to Independence: Characteristics and Outcomes of Mentored Career Development (KL2) Scholars at Clinical and Translational Science Award Institutions

artículo científico publicado en 2017

Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.

artículo científico publicado en 2005

Understanding Career Success and Its Contributing Factors for Clinical and Translational Investigators

artículo científico publicado en 2015

Lista de obras de

2426 Fostering cross-disciplinary research: Lessons learned from STTEP-UP

2502 The need for an evidence-based CTS specific IDP for early career training and for a long-term and sustainable career in clinical translational sciences

2515 Cure Quest: Teaching the complexities of drug discovery and development through an adventure game

2517 Learning to LEAD: Leadership emerging in academic departments

2518 InCHOIR learning lab: A TL1 and workforce development initiative at Mount Sinai

2527 Mount Sinai health hackathon: Harnessing the power of collaboration to advance experiential team science education

2547: Sinai MedMaker Challenge: A model of experiential team science education

3144 Exploring communication and collaboration at the Mount Sinai Health Hackathon: a social network analysis

3297 What do early career researchers need? Exploring early career researchers’ learning needs to develop an Emerging Investigator website

3366 Communication in Science: a summer workshop program at Mount Sinai

A path forward: Global health, telemedicine, and hematology

Accelerators: Sparking Innovation and Transdisciplinary Team Science in Disparities Research

An analysis of current neutropenia therapies, including pegfilgrastim

Anemia and the elderly: clinical considerations

Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells

Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks

Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study.

Benefits of epoetin alfa in anemic breast cancer patients receiving chemotherapy

Cancer incidence in World Trade Center rescue and recovery workers, 2001-2008

Clinical benefits of epoetin alfa therapy in patients with lung cancer

Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes

Creating effective career development programs

Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1 ⬇️

Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity

Granulocyte colony stimulating factor for mucositis during post-operative radiotherapy

Intraoperative acute tumor lysis syndrome during laparoscopic splenectomy preceded by splenic artery embolization

Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia ⬇️

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma

Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes

Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors

Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IP

Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.

Prospective cohort study of the circadian rhythm pattern in allogeneic sibling donors undergoing standard granulocyte colony-stimulating factor mobilization

Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL.

Signaling pathways in lymphoma: pathogenesis and therapeutic targets

Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells

Statistical explanations for a community-based study of once-weekly epoetin alfa therapy in patients receiving chemotherapy

Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators.

Transition to Independence: Characteristics and Outcomes of Mentored Career Development (KL2) Scholars at Clinical and Translational Science Award Institutions

Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.

Understanding Career Success and Its Contributing Factors for Clinical and Translational Investigators